• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导致终板乙酰胆碱酯酶缺乏的突变谱。

The spectrum of mutations causing end-plate acetylcholinesterase deficiency.

作者信息

Ohno K, Engel A G, Brengman J M, Shen X M, Heidenreich F, Vincent A, Milone M, Tan E, Demirci M, Walsh P, Nakano S, Akiguchi I

机构信息

Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Ann Neurol. 2000 Feb;47(2):162-70.

PMID:10665486
Abstract

The end-plate species of acetylcholinesterase (AChE) is an asymmetric enzyme consisting of a collagenic tail subunit composed of three collagenic strands (ColQ), each attached to a tetramer of the T isoform of the catalytic subunit (AChE(T)) via a proline-rich attachment domain. The principal function of the tail subunit is to anchor asymmetric AChE in the synaptic basal lamina. Human end-plate AChE deficiency was recently shown to be caused by mutations in COLQ. We here report nine novel COLQ mutations in 7 patients with end-plate AChE deficiency. We examine the effects of the mutations on the assembly of asymmetric AChE by coexpressing each genetically engineered COLQ mutant with ACHE(T) in COS cells. We classify the newly recognized and previously reported COLQ mutations into four classes according to their position in ColQ and their effect on AChE expression. We find that missense mutations in the proline-rich attachment domain abrogate attachment of catalytic subunits, that truncation mutations in the ColQ collagen domain prevent the assembly of asymmetric AChE, that hydrophobic missense residues in the C-terminal domain prevent triple helical assembly of the ColQ collagen domain, and that other mutations in the C-terminal region produce asymmetric species of AChE that are likely insertion incompetent.

摘要

乙酰胆碱酯酶(AChE)的终板型是一种不对称酶,由一个胶原尾部亚基组成,该亚基由三条胶原链(ColQ)构成,每条链通过富含脯氨酸的连接结构域与催化亚基(AChE(T))的T同工型四聚体相连。尾部亚基的主要功能是将不对称AChE锚定在突触基底膜中。最近发现人类终板AChE缺乏症是由COLQ突变引起的。我们在此报告了7例终板AChE缺乏症患者中的9种新的COLQ突变。我们通过在COS细胞中共表达每个基因工程化的COLQ突变体与ACHE(T),来研究这些突变对不对称AChE组装的影响。我们根据新识别的和先前报道的COLQ突变在ColQ中的位置及其对AChE表达的影响,将它们分为四类。我们发现富含脯氨酸的连接结构域中的错义突变消除了催化亚基的连接,ColQ胶原结构域中的截短突变阻止了不对称AChE的组装,C末端结构域中的疏水性错义残基阻止了ColQ胶原结构域的三螺旋组装,并且C末端区域中的其他突变产生了可能无法插入的不对称AChE种类。

相似文献

1
The spectrum of mutations causing end-plate acetylcholinesterase deficiency.导致终板乙酰胆碱酯酶缺乏的突变谱。
Ann Neurol. 2000 Feb;47(2):162-70.
2
Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme.由不对称酶的胶原样尾部亚基(ColQ)突变引起的人类终板乙酰胆碱酯酶缺乏症。
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9654-9. doi: 10.1073/pnas.95.16.9654.
3
Three novel COLQ mutations and variation of phenotypic expressivity due to G240X.三个新的COLQ突变以及由G240X导致的表型表达变异。
Neurology. 2002 Feb 26;58(4):603-9. doi: 10.1212/wnl.58.4.603.
4
Mutations in the C-terminal domain of ColQ in endplate acetylcholinesterase deficiency compromise ColQ-MuSK interaction.C 末端结构域的突变在板层乙酰胆碱酯酶缺乏症中影响 ColQ-MuSK 的相互作用。
Hum Mutat. 2013 Jul;34(7):997-1004. doi: 10.1002/humu.22325. Epub 2013 Apr 19.
5
Congenital end-plate acetylcholinesterase deficiency caused by a nonsense mutation and an A-->G splice-donor-site mutation at position +3 of the collagenlike-tail-subunit gene (COLQ): how does G at position +3 result in aberrant splicing?由胶原蛋白样尾亚基基因(COLQ)第+3位的无义突变和A→G剪接供体位点突变引起的先天性终板乙酰胆碱酯酶缺乏症:+3位的G是如何导致异常剪接的?
Am J Hum Genet. 1999 Sep;65(3):635-44. doi: 10.1086/302551.
6
COOH-terminal collagen Q (COLQ) mutants causing human deficiency of endplate acetylcholinesterase impair the interaction of ColQ with proteins of the basal lamina.COOH 末端胶原蛋白 Q(COLQ)突变导致人类终板乙酰胆碱酯酶缺乏,损害 ColQ 与基底膜蛋白的相互作用。
Hum Genet. 2014 May;133(5):599-616. doi: 10.1007/s00439-013-1391-3. Epub 2013 Nov 27.
7
Two novel mutations in the COLQ gene cause endplate acetylcholinesterase deficiency.COLQ基因中的两个新突变导致终板乙酰胆碱酯酶缺乏。
Neuromuscul Disord. 2003 Mar;13(3):236-44. doi: 10.1016/s0960-8966(02)00243-2.
8
C-terminal and heparin-binding domains of collagenic tail subunit are both essential for anchoring acetylcholinesterase at the synapse.胶原蛋白尾亚基的C末端和肝素结合结构域对于将乙酰胆碱酯酶锚定在突触处均至关重要。
J Biol Chem. 2004 Mar 19;279(12):10997-1005. doi: 10.1074/jbc.M305462200. Epub 2003 Dec 31.
9
Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.COLQ 基因突变所致先天性肌无力综合征的临床及分子遗传学发现
Brain. 2008 Mar;131(Pt 3):747-59. doi: 10.1093/brain/awm325. Epub 2008 Jan 7.
10
Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic).人类乙酰胆碱酯酶相关胶原基因COLQ的突变是导致终板乙酰胆碱酯酶缺乏的先天性肌无力综合征(Ic型)的原因。
Am J Hum Genet. 1998 Oct;63(4):967-75. doi: 10.1086/302059.

引用本文的文献

1
An α7 nicotinic and GABA receptor-mediated pathway controls acetylcholine release in the tripartite neuromuscular junction.一条由α7烟碱型和GABA受体介导的通路控制着三联体神经肌肉接头处的乙酰胆碱释放。
J Physiol. 2025 Jan;603(2):507-527. doi: 10.1113/JP287243. Epub 2024 Dec 30.
2
Molecular Analysis of a Congenital Myasthenic Syndrome Due to a Pathogenic Variant Affecting the C-Terminus of ColQ.ColQ 羧基末端致病性变异导致先天性肌无力综合征的分子分析
Int J Mol Sci. 2023 Nov 11;24(22):16217. doi: 10.3390/ijms242216217.
3
Expression assay of the in a family with congenital myasthenic syndrome and symptomatic carriers.
先天性肌无力综合征家族及有症状携带者中[具体基因或蛋白名称未给出]的表达分析。
Clin Case Rep. 2023 Oct 23;11(10):e8062. doi: 10.1002/ccr3.8062. eCollection 2023 Oct.
4
COLQ-related congenital myasthenic syndrome: An integrative view.COLQ 相关先天性肌无力综合征:综合观点。
Neurogenetics. 2023 Jul;24(3):189-200. doi: 10.1007/s10048-023-00719-7. Epub 2023 May 25.
5
Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review.先天性肌营养不良症的临床与病理特征 35 个基因-全面综述。
Int J Mol Sci. 2023 Feb 13;24(4):3730. doi: 10.3390/ijms24043730.
6
Pharmacological Treatments for Congenital Myasthenic Syndromes Caused by Mutations.先天性肌营养不良症致药物治疗突变。
Curr Neuropharmacol. 2023;21(7):1594-1605. doi: 10.2174/1570159X21666230126145652.
7
5-Aryl-1,3,4-oxadiazol-2-amines Decorated with Long Alkyl and Their Analogues: Synthesis, Acetyl- and Butyrylcholinesterase Inhibition and Docking Study.带有长链烷基修饰的5-芳基-1,3,4-恶二唑-2-胺及其类似物:合成、乙酰胆碱酯酶和丁酰胆碱酯酶抑制作用及对接研究
Pharmaceuticals (Basel). 2022 Mar 25;15(4):400. doi: 10.3390/ph15040400.
8
Cholinesterases in Tripartite Neuromuscular Synapse.三联体神经肌肉突触中的胆碱酯酶
Front Mol Neurosci. 2021 Dec 23;14:811220. doi: 10.3389/fnmol.2021.811220. eCollection 2021.
9
Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up.土耳其先天性肌无力综合征:临床线索和长期随访预后。
Neuromuscul Disord. 2018 Apr;28(4):315-322. doi: 10.1016/j.nmd.2017.11.013. Epub 2017 Nov 28.
10
COLQ variant associated with Devon Rex and Sphynx feline hereditary myopathy.与德文卷毛猫和加拿大无毛猫遗传性肌病相关的COLQ变体。
Anim Genet. 2015 Dec;46(6):711-5. doi: 10.1111/age.12350. Epub 2015 Sep 16.